These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2028023)
1. Modification of tumor development in the urinary bladder. Fukushima S Prog Exp Tumor Res; 1991; 33():154-74. PubMed ID: 2028023 [No Abstract] [Full Text] [Related]
2. Maintenance by saccharin of membrane alterations of rat bladder cells induced by subcarcinogenic treatment with bladder carcinogens. Kakizoe T; Komatsu H; Niijima T; Kawachi T; Sugimura T Cancer Res; 1981 Nov; 41(11 Pt 1):4702-5. PubMed ID: 7306987 [TBL] [Abstract][Full Text] [Related]
3. Effects of sodium salts of phenobarbital and barbital on development of bladder tumors in male F344/NCr rats pretreated with either N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-nitrosobutyl-4-hydroxybutylamine. Diwan BA; Hagiwara A; Ward JM; Rice JM Toxicol Appl Pharmacol; 1989 Apr; 98(2):269-77. PubMed ID: 2711390 [TBL] [Abstract][Full Text] [Related]
4. Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-methyl-N-nitrosourea. Masui T; Mann AM; Macatee TL; Garland EM; Okamura T; Smith RA; Cohen SM Carcinogenesis; 1991 Oct; 12(10):1975-8. PubMed ID: 1682063 [TBL] [Abstract][Full Text] [Related]
5. Effect of partial cystectomy on the induction of pre-neoplastic lesions in rat bladder initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by bladder carcinogens and promoters. Fukushima S; Hirose M; Okuda M; Nakanowatari J; Hatano A; Ito N Urol Res; 1982; 10(3):115-8. PubMed ID: 7135697 [TBL] [Abstract][Full Text] [Related]
6. [Experimental replication of bladder tumors. Morphologic features of early stages of their development]. Anichkov NM Vestn Akad Med Nauk SSSR; 1979; (9):85-90. PubMed ID: 386636 [No Abstract] [Full Text] [Related]
7. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Jacobs JB; Arai M; Cohen SM; Friedell GH Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108 [TBL] [Abstract][Full Text] [Related]
8. Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder. Murasaki G; Cohen SM Carcinogenesis; 1983; 4(1):97-9. PubMed ID: 6821891 [TBL] [Abstract][Full Text] [Related]
9. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats. Cohen SM; Ellwein LB; Okamura T; Masui T; Johansson SL; Smith RA; Wehner JM; Khachab M; Chappel CI; Schoenig GP Cancer Res; 1991 Apr; 51(7):1766-77. PubMed ID: 2004360 [TBL] [Abstract][Full Text] [Related]
10. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats. Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810 [TBL] [Abstract][Full Text] [Related]
11. Rat bladder isograft model for focal carcinoma. Mei H; Hagen IK; Allhoff EP; Lin JC; Chapman CM; Proppe KH; Prout GR; Lin CW J Urol; 1982 Sep; 128(3):629-32. PubMed ID: 7120581 [TBL] [Abstract][Full Text] [Related]
12. N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder cancer in mice: augmentation by sutures through the bladder wall. Chester JF; Gaissert HA; Ross JS; Malt RA; Weitzman SA J Urol; 1987 Apr; 137(4):769-71. PubMed ID: 3560345 [TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of antitumor-B and retinamide on precancerous lesions of the bladder in rats]. Fan X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):71-3. PubMed ID: 8324843 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of dimethylhydrazine bowel carcinogenesis in rats. Steele G; Crissey M; Gittes R; Harte P; Wilson R; Corson J Cancer; 1981 May; 47(9):2218-21. PubMed ID: 7226115 [TBL] [Abstract][Full Text] [Related]
15. Lack of involvement of p53 gene mutations in N-methyl-N-nitrosourea-induced bladder tumor progression in N-butyl-N-(4-hydroxybutyl)nitrosamine-treated rats and no suppression by indomethacin. Ozaki M; Shibata MA; Takahashi S; Orita SI; Kawabe M; Shirai T Cancer Lett; 1997 May; 115(2):249-55. PubMed ID: 9149132 [TBL] [Abstract][Full Text] [Related]
16. Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion. Birt DF; Julius AD; Hasegawa R; St John M; Cohen SM Cancer Res; 1987 Mar; 47(5):1244-50. PubMed ID: 3815336 [TBL] [Abstract][Full Text] [Related]
17. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Fukushima S; Friedell GH; Jacobs JB; Cohen SM Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063 [TBL] [Abstract][Full Text] [Related]
19. Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. Ito N Cancer Res; 1976 Jul; 36(7 PT 2):2528-31. PubMed ID: 1277162 [No Abstract] [Full Text] [Related]